Mirum Pharmaceuticals (MIRM) Intangibles (2021 - 2026)

Mirum Pharmaceuticals' Intangibles history runs 6 years deep, the most recent figure standing at $254.2 million for Q1 2026.

• On a quarterly basis, Intangibles rose 4.23% year-over-year to $254.2 million in Q1 2026; TTM through Mar 2026 was $254.2 million, a 4.23% increase from a year earlier, with the FY2025 full-year figure at $260.9 million, up 4.44% from the prior year.
• Intangibles fell to $254.2 million in Q1 2026 per MIRM's latest filing, from $260.9 million in the prior quarter.
• Across five years, Intangibles topped out at $261.8 million in Q2 2024 and bottomed at $18.5 million in Q1 2022.
• The 5-year median for Intangibles is $243.8 million (2025), against an average of $179.3 million.
• Across the five-year window, Intangibles soared 473.68% in 2023 and fell 9.34% in 2025, its largest moves.
• Year by year, Intangibles stood at $59.0 million in 2022, then surged by 329.02% to $252.9 million in 2023, then declined by 1.23% to $249.8 million in 2024, then climbed by 4.44% to $260.9 million in 2025, then dropped by 2.59% to $254.2 million in 2026.
• Per Business Quant, the three latest MIRM Intangibles figures stand at $254.2 million (Q1 2026), $260.9 million (Q4 2025), and $231.9 million (Q3 2025).